Published in Health Risk Factor Week, April 11th, 2006
In this study, published in the Puerto Rico Health Sciences Journal, vol. 24 (4): 269-276, a phase I clinical trial with 24 terminal cancer patients receiving between 10-60 grams of sodium ascorbate daily for 8 weeks, adverse effects were reportedly minor. "The results presented in this manuscript should allay fears about the safety of 'mega-dose' vitamin C," said Dr. Joseph Casciari, coauthor of the manuscript.
This research comes on the heels of independent studies demonstrating efficacy of high-dose...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.